AzTrials
AzTrials

Post-traumatic Stress Disorder (PTSD)FlashGP-EQNCT07672613

EMDR Flash Group Protocol for Earthquake Survivors

A study testing EMDR Flash Group Protocol in people with Post-traumatic Stress Disorder (PTSD) and Acute Stress Disorder, run by Istanbul Galata University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This pilot randomized controlled trial evaluated the preliminary effects of the online EMDR Flash Group Protocol among adults affected by the 2023 Kahramanmaraş earthquakes in Türkiye. Participants were randomly assigned to either the EMDR Flash Group Protocol or a waitlist control group. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
EMDR Flash Group Protocol
Could I receive a placebo?
No, everyone receives an active treatment
How many people
410 participants
Where
1 siteTurkey (Türkiye)
Study dates
2 Mar 2023to 25 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age 18 years or older
  • Present in the earthquake-affected region during the 2023 Kahramanmaraş earthquakes
  • Directly experienced the earthquake or were affected through disaster-related exposure
  • Ability to participate in online sessions
  • Access to the necessary technological equipment and internet connection
  • Ability to provide informed consent

Who cannot join

  • Intellectual disability
  • Current or past psychotic disorder (e.g., schizophrenia)
  • Bipolar disorder
  • History of severe head trauma
  • Inability to participate in the online intervention format

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istanbul Galata University

    Istanbul, Istanbul

Other trials in Turkey (Türkiye)

About this study

Official title: Preliminary Effects of an Early EMDR Flash Group Intervention on Traumatic Stress, Anxiety, and Depressive Symptoms Among Earthquake Survivors: A Pilot Randomized Controlled Trial

This pilot randomized controlled trial evaluated the preliminary effects of the online EMDR Flash Group Protocol among adults affected by the 2023 Kahramanmaraş earthquakes in Türkiye. Participants were randomly assigned to either the EMDR Flash Group Protocol or a waitlist control group. The primary outcome was change in posttraumatic stress symptoms measured by the PTSD Checklist for DSM-5 (PCL-5). Secondary outcomes included depression, anxiety, and stress symptoms measured by the Depression Anxiety Stress Scale-21 (DASS-21). Outcomes were assessed at baseline and at 3-month follow-up.

Read the detailed description

The Kahramanmaraş earthquakes of February 2023 affected millions of people and were associated with substantial psychological distress, including posttraumatic stress, anxiety, and depressive symptoms. Early psychological interventions may help reduce acute distress and improve posttraumatic outcomes following disaster exposure.

This pilot randomized controlled trial was conducted approximately one month after the earthquakes. Adults affected by the disaster were recruited online and randomized in a 1:1 ratio to either the EMDR Flash Group Protocol intervention or a waitlist control condition. The intervention was delivered online via Zoom by trained mental health professionals using a standardized protocol consisting of two group sessions.

The primary objective was to evaluate the preliminary effects of the EMDR Flash Group Protocol on posttraumatic stress symptoms. Secondary objectives were to evaluate changes in depression, anxiety, and stress symptoms. Outcomes were assessed using self-report measures at baseline and at 3-month follow-up.

This study was conducted as a pilot trial to evaluate the feasibility and preliminary effectiveness of the intervention following a large-scale natural disaster.

Being tested
EMDR Flash Group Protocol
Keywords
Flash Technique, EMDR, Flash Group Protocol, Early Intervention, Kahramanmaras Earthquake, Telemedicine, PTSD, Traumatic Stress
Medical subject headings
Stress Disorders, Post-Traumatic, Stress Disorders, Traumatic, Acute, Anxiety Disorders, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EMDR Flash Group ProtocolBehavioural

    The EMDR Flash Group Protocol was delivered online via Zoom by trained mental health professionals. The intervention consisted of two group sessions lasting approximately 60-90 minutes and was administered approximately one month after the 2023 Kahramanmaraş earthquakes.

Study groups in NCT07672613
Study groupRoleWhat they receive
EMDR Flash Group ProtocolExperimentalParticipants received the online EMDR Flash Group Protocol delivered by trained mental health professionals. The intervention consisted of two group sessions lasting approximately 60 to 90 minutes and was conducted via Zoom approximately one month after the 2023 Kahramanmaraş earthquakes.
Receives: Behavioral: EMDR Flash Group Protocol
Waitlist ControlNo interventionParticipants assigned to the waitlist control group did not receive the EMDR Flash Group Protocol during the study period and completed the same assessment schedule as the intervention group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in PTSD Symptoms (PCL-5 Total Score)

    Change in posttraumatic stress symptom severity measured by the PTSD Checklist for DSM-5 (PCL-5) total score from baseline to 3-month follow-up.

    Measured: Assessed at baseline (pre-intervention) and at 3-month follow-up.

Secondary outcomes (3)
  1. Change in Depression Symptoms (DASS-21 Depression)

    Change in depression symptom severity measured by the Depression Anxiety Stress Scale-21 (DASS-21) Depression subscale from baseline to 3-month follow-up.

    Measured: Assessed at baseline (pre-intervention) and at 3-month follow-up.

  2. Change in Anxiety Symptoms (DASS-21 Anxiety)

    Change in anxiety symptom severity measured by the DASS-21 Anxiety subscale from baseline to 3-month follow-up.

    Measured: Assessed at baseline (pre-intervention) and at 3-month follow-up.

  3. Change in Stress Symptoms (DASS-21 Stress)

    Change in depression symptom severity measured by the Depression Anxiety Stress Scale-21 (DASS-21) Depression subscale from baseline to 3-month follow-up.

    Measured: Assessed at baseline (pre-intervention) and at 3-month follow-up.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jun 2026
  2. Study start2 Mar 2023
  3. Primary completion20 Jun 2023
  4. Study completion25 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants were randomly assigned in a 1:1 ratio to either the EMDR Flash Group Protocol or a waitlist control condition.
Masking
None (open label)
Enrolment
410 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07672613
Sponsor's protocol ID
EMDRFLASHGP-2023-RCT
Acronym
FlashGP-EQ
Status last verified
Jun 2026
First submitted
23 Jun 2026
Last updated
29 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing EMDR Flash Group Protocol in people with Post-traumatic Stress Disorder (PTSD) and Acute Stress Disorder, run by Istanbul Galata University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in PTSD Symptoms (PCL-5 Total Score) (time frame: Assessed at baseline (pre-intervention) and at 3-month follow-up.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in